Characterization of Muscle Activity During a Surface EMG-controlled Rehabilitation Game
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 7 and 85 years old?
Source: NCT07838688, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Rennes University Hospital
- Trial code
- NCT07838688
- Record updated
- 24 September 2026
- Original description
The aim of this pilot study is to evaluate muscular activity during a single session of surface electromyography controlled exergame (muscle activation, number of contraction…) in cerebral palsy kids, hemiparetic adults and healthy controls.Read full original descriptionShow less
The aim of this pilot study is to evaluate muscular activity during a single session of surface electromyography controlled exergame (muscle activation, number of contraction…) in cerebral palsy kids, hemiparetic adults and healthy controls.
Secondary aims are to assess different game mode (one-player, coactive two-player or competitive two-player and different gameplay (a rhythm and a platform gameplay) on muscle activation, number of contraction and on participant's experiences. Another aim is to assess enjoyment, motivation, flow and usability in hemiparetics adults.
Inclusion: Participants with cerebral palsy who are able to walk, GMFCS stages I through III, hemiplegic, diplegic, or quadriplegic; Aged 7 to 17 years; With palpable contractions of the target muscles (triceps surae and tibialis anterior) (≥ 1 on the Medical Research Council [MRC] scale); Having received verbal and written information about the protocol, having agreed to participate in this study, and having signed a consent form if the participant is 15 years of age or older; Signed consent for participation from the participant's legal guardians; Enrolled, either personally or through their parents, in a social security program; Stroke in the subacute or chronic phase; Aged 18 to 85 years; With palpable contractions of the target muscles (triceps surae and tibialis anterior) (≥ 1 on the Medical Research Council [MRC] scale); Having received verbal and written information about the protocol and having signed a consent form to participate in this study; Enrolled in a social security program; Aged 18 to 85; No neurological disorders; Who received verbal and written information about the protocol and signed a consent form to participate in this study.
Exclusion: Surgery on the lower extremities within the past 6 months; Participating in another therapeutic or drug intervention study that could affect this study; A botulinum toxin injection into the triceps surae and/or the tibialis anterior within the past 3 months; Pain during dorsiflexion or plantarflexion of the ankle joint; Cognitive impairments limiting participation; A person referred to in Articles L1121-5, L1121-6, L2121-8, L1121-9 of the Public Health Code.